Coherus BioSciences, Inc.·4

Feb 5, 4:07 PM ET

Watler Peter K. 4

4 · Coherus BioSciences, Inc. · Filed Feb 5, 2018

Insider Transaction Report

Form 4
Period: 2018-02-01
Watler Peter K.
Chief Technical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-02-01+50,00050,000 total
    Exercise: $10.05Exp: 2028-02-01Common Stock (50,000 underlying)
Holdings
  • Common Stock, $0.0001 par value

    5,900
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION